{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T08:20:03Z","timestamp":1793262003817,"version":"4.5.0"},"publisher-location":"Chichester, UK","reference-count":92,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd006401.pub3","type":"reference-entry","created":{"date-parts":[[2014,7,23]],"date-time":"2014-07-23T15:52:25Z","timestamp":1406130745000},"source":"Crossref","is-referenced-by-count":14,"title":["Statins for children with familial hypercholesterolemia"],"prefix":"10.1002","author":[{"given":"Alpo","family":"Vuorio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaana","family":"Kuoppala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petri T","family":"Kovanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve E","family":"Humphries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Tonstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Wiegman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Euridiki","family":"Drogari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,7,23]]},"reference":[{"issue":"11","key":"10.1002\/14651858.CD006401.pub3-BIB1|cit1","first-page":"1121","article-title":"Efficacy and safety of rosuvastatin therapy for children with familial hypercholesterolemia","volume":"55","author":"Avis","year":"2010","journal-title":"Pediatric Cardiology"},{"issue":"3","key":"10.1002\/14651858.CD006401.pub3-BIB2|cit2","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1542\/peds.2004-2090","article-title":"Pediatrics Efficacy and safety of lovastatin therapy in adolescent girls with heterozygous familial hypercholesterolemia","volume":"116","author":"Clauss","year":"2005","journal-title":"Pediatrics"},{"issue":"6","key":"10.1002\/14651858.CD006401.pub3-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1161\/01.ATV.18.6.1007","article-title":"Association of specific LDL receptor gene mutations with differential plasma lipoprotein response to simvastatin in young French Canadian with heterozygous familial hypercholesterolemia","volume":"18","author":"Couture","year":"1998","journal-title":"Arteriosclerosis Thrombosis and Vascular Biology"},{"issue":"32","key":"10.1002\/14651858.CD006401.pub3-BIB4|cit4","first-page":"157","article-title":"Efficacy, safety and tolerability of simvastatin in children with familial hypercholesterolaemia: rationale, design, and baseline characteristics","volume":"11","author":"Jongh","year":"2003","journal-title":"Clinical Biochemistry and Metabolism"},{"issue":"12","key":"10.1002\/14651858.CD006401.pub3-BIB5|cit5","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1016\/S0735-1097(02)02593-7","article-title":"Early statin therapy restores endothelial function in children with familial hypercholesterolemia","volume":"40","author":"Jongh","year":"2002","journal-title":"Journal of the American College of Cardiology"},{"issue":"17","key":"10.1002\/14651858.CD006401.pub3-BIB6|cit6","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1161\/01.CIR.0000035247.42888.82","article-title":"Efficacy and safety of statin therapy in children with familial hypercholesterolemia: A randomized, double-blind, placebo-controlled trial with simvastatin","volume":"106","author":"Jongh","year":"2002","journal-title":"Circulation"},{"issue":"8","key":"10.1002\/14651858.CD006401.pub3-BIB7|cit7","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2165\/00044011-200222080-00005","article-title":"Efficacy, safety and tolerability of simvastatin in children with familial hypercholesterolaemia","volume":"22","author":"Jongh","year":"2002","journal-title":"Clinical Drug Investigation"},{"issue":"5","key":"10.1002\/14651858.CD006401.pub3-BIB8|cit8","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1203\/00006450-199605000-00021","article-title":"Short-term efficacy and safety of pravastatin in 72 children with familial hypercholesterolemia","volume":"39","author":"Knipscheer","year":"1996","journal-title":"Pediatric Research"},{"issue":"1","key":"10.1002\/14651858.CD006401.pub3-BIB9|cit9","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0022-3476(03)00186-0","article-title":"Efficacy and safety of atorvastatin in children and adolescents with a familial hypercholesterolemia or severe hyperlipidemia: A multicenter, randomized, placebo-controlled trial","volume":"143","author":"McCrindle","year":"2003","journal-title":"Journal of Pediatrics"},{"issue":"2","key":"10.1002\/14651858.CD006401.pub3-BIB10|cit10","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1001\/jama.281.2.137","article-title":"Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia","volume":"281","author":"Stein","year":"1999","journal-title":"JAMA"},{"issue":"3","key":"10.1002\/14651858.CD006401.pub3-BIB11|cit11","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1001\/jama.292.3.331","article-title":"Efficacy and safety of statin therapy in children with familial hypercholesterolemia","volume":"292","author":"Wiegman","year":"2004","journal-title":"JAMA"},{"issue":"1","key":"10.1002\/14651858.CD006401.pub3-BIB12|cit12","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0021-9150(02)00005-9","article-title":"Long-term treatment with atorvastatin in adolescent males with heterozygous familial hypercholesterolemia","volume":"163","author":"Athyros","year":"2002","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1002\/14651858.CD006401.pub3-BIB13|cit13","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2165\/11591650-000000000-00000","article-title":"Long-term follow-up of statin treatment in a cohort of children with familial hypercholesterolemia: Efficacy and tolerability","volume":"13","author":"Carreau","year":"2011","journal-title":"Pediatric Drugs"},{"issue":"6","key":"10.1002\/14651858.CD006401.pub3-BIB14|cit14","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00431-003-1181-3","article-title":"The effect of low-dose simvastatin in children with familial hypercholesterolemia: a 1-year observation","volume":"162","author":"Dirisamer","year":"2003","journal-title":"European Journal of Pediatrics"},{"key":"10.1002\/14651858.CD006401.pub3-BIB15|cit15","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00246-011-9885-z","article-title":"An eight-week trial investigating the efficacy and tolerability of atorvastatin for children and adolescents with heterozygous familial hypercholesterolemia","volume":"32","author":"Gandelman","year":"2011","journal-title":"Pediatric Cardiology"},{"issue":"2","key":"10.1002\/14651858.CD006401.pub3-BIB16|cit16","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0009-9236(03)00153-X","article-title":"Pharmacokinetics and pharmacodynamics of pravastatin in children with familial hypercholesterolemia","volume":"74","author":"Hedman","year":"2003","journal-title":"Clinical Pharmacology and Therapy"},{"issue":"4","key":"10.1002\/14651858.CD006401.pub3-BIB17|cit17","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1210\/jc.2004-1541","article-title":"Efficacy and safety of pravastatin in children and adolescents with heterozygous familial hypercholesterolemia: A prospective clinical follow-up study","volume":"90","author":"Hedman","year":"2005","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"5","key":"10.1002\/14651858.CD006401.pub3-BIB18|cit18","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1542\/peds.97.5.619","article-title":"Treatment of familial hypercholesterolemia in children and adolescents: Effect of lovastatin","volume":"97","author":"Lambert","year":"1996","journal-title":"Pediatrics"},{"issue":"6","key":"10.1002\/14651858.CD006401.pub3-BIB19|cit19","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1203\/00006450-200206000-00009","article-title":"A randomized crossover trial of combination pharmacologic therapy in children with familial hyperlipidemia","volume":"51","author":"McCrindle","year":"2002","journal-title":"Pediatric Research"},{"issue":"1","key":"10.1002\/14651858.CD006401.pub3-BIB20|cit20","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0021-9150(96)06007-8","article-title":"Statin therapy in a kindred with both apolipoprotein B and low-density lipoprotein receptor gene defects","volume":"129","author":"Raal","year":"1997","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1002\/14651858.CD006401.pub3-BIB21|cit21","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1365-2125.2003.02044.x","article-title":"Professional athletes suffering from familial hypercholesterolemia rarely tolerate statin treatment because of muscular problems","volume":"57","author":"Sinzinger","year":"2004","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"1","key":"10.1002\/14651858.CD006401.pub3-BIB22|cit22","first-page":"23","article-title":"Diet only and diet plus simvastatin in the treatment of heterozygous familial hypercholesterolemia in childhood","volume":"25","author":"Stefanutti","year":"1999","journal-title":"Drugs Under Experimental and Clinical Research"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD006401.pub3-BIB23|cit23","doi-asserted-by":"crossref","first-page":"I145","DOI":"10.1016\/0021-9150(89)90171-8","article-title":"Treatment of familial hypercholesterolemia with drugs in children","volume":"9","author":"Stein","year":"1989","journal-title":"Arteriosclerosis"},{"issue":"11","key":"10.1002\/14651858.CD006401.pub3-BIB24|cit24","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1080\/08035250600702602","article-title":"Efficacy and safety of fluvastatin in children and adolescents with heterozygous familial hypercholesterolemia","volume":"95","author":"Graaf","year":"2006","journal-title":"Acta Paediatrica"},{"issue":"2","key":"10.1002\/14651858.CD006401.pub3-BIB25|cit25","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.atherosclerosis.2006.09.030","article-title":"Statin treatment for children and adolescents with heterozygous familial hypercholesterolaemia: A systematic review and meta-analysis","volume":"195","author":"Arambepola","year":"2007","journal-title":"Atherosclerosis"},{"issue":"8","key":"10.1002\/14651858.CD006401.pub3-BIB26|cit26","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1161\/ATVBAHA.107.145151","article-title":"A systematic review and meta-analysis of statin therapy in children with familial hypercholesterolemia","volume":"27","author":"Avis","year":"2007","journal-title":"Arteriosclerosis Thrombosis and Vascular Biology"},{"issue":"2","key":"10.1002\/14651858.CD006401.pub3-BIB27|cit27","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1177\/106002800303700220","article-title":"Association of HMG-CoA reductase inhibitors with neuropathy","volume":"37","author":"Backes","year":"2003","journal-title":"Annals of Pharmacotherapy"},{"issue":"8A","key":"10.1002\/14651858.CD006401.pub3-BIB28|cit28","doi-asserted-by":"crossref","first-page":"6C","DOI":"10.1016\/j.amjcard.2005.12.006","article-title":"Statin safety: An overview an assessment of the data - 2005","volume":"97","author":"Bays","year":"2006","journal-title":"American Journal of Cardiology"},{"issue":"3","key":"10.1002\/14651858.CD006401.pub3-BIB29|cit29","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2174\/157488609789006949","article-title":"Adverse effects of statins - mechanisms and consequences","volume":"4","author":"Beltowski","year":"2009","journal-title":"Current Drug Safety"},{"issue":"1","key":"10.1002\/14651858.CD006401.pub3-BIB30|cit30","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/archinte.1991.00400010067008","article-title":"Expanded clinical evaluation of lovastatin (EXCEL) study results. I. Efficacy in modifying plasma lipoproteins and adverse event profile in 8245 patients with moderate hypercholesterolemia","volume":"151","author":"Bradford","year":"1991","journal-title":"Archives of Internal Medicine"},{"issue":"8A","key":"10.1002\/14651858.CD006401.pub3-BIB31|cit31","doi-asserted-by":"crossref","first-page":"86C","DOI":"10.1016\/j.amjcard.2005.12.017","article-title":"National Lipid Association Statin Safety Task Force Neurology Expert Panel: An assessment of statin safety by neurologist","volume":"97","author":"Brass","year":"2006","journal-title":"American Journal of Cardiology"},{"key":"10.1002\/14651858.CD006401.pub3-BIB32|cit32","doi-asserted-by":"crossref","first-page":"f2610. doi: 10.","DOI":"10.1136\/bmj.f2610","article-title":"Risk of incident diabetes among patients treated with statins: population based study","volume":"346","author":"Carter","year":"2013","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD006401.pub3-BIB33|cit33","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0039-6257(96)82007-8","article-title":"Cholesterol and cataracts","volume":"40","author":"Cenedella","year":"1996","journal-title":"Survey of Opthalmology"},{"issue":"5","key":"10.1002\/14651858.CD006401.pub3-BIB34|cit34","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1053\/j.gastro.2004.02.015","article-title":"Patients with elevated liver enzymes are not at higher risk for statin hepatotoxicity","volume":"126","author":"Chalasani","year":"2004","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1002\/14651858.CD006401.pub3-BIB35|cit35","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.annepidem.2009.10.007","article-title":"Persistence with statins and incident cataract: a population-based historical cohort study","volume":"20","author":"Chodick","year":"2010","journal-title":"Annals of Epidemiology"},{"issue":"9","key":"10.1002\/14651858.CD006401.pub3-BIB36|cit36","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1592\/phco.24.13.1194.38084","article-title":"Statin-associated peripheral neuropathy: Review of the literature","volume":"24","author":"Chong","year":"2004","journal-title":"Pharmacotherapy"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD006401.pub3-BIB37|cit37","first-page":"S77","article-title":"An assessment of statin safety by hepatologists","volume":"8","author":"Cohen","year":"2007","journal-title":"American Journal of Cardiology"},{"issue":"1","key":"10.1002\/14651858.CD006401.pub3-BIB38|cit38","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1542\/peds.2008-1349","article-title":"Lipid screening and cardiovascular health in children","volume":"122","author":"Daniels","year":"2008","journal-title":"Pediatrics"},{"issue":"5","key":"10.1002\/14651858.CD006401.pub3-BIB39|cit39","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1592\/phco.24.6.584.34738","article-title":"Statins and live toxicity: a meta-analysis","volume":"24","author":"Denus","year":"2004","journal-title":"Pharmacotherapy"},{"issue":"12","key":"10.1002\/14651858.CD006401.pub3-BIB40|cit40","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1016\/S0735-1097(02)02593-7","article-title":"Early statin therapy restores endothelial function in children with familial hypercholesterolemia","volume":"40","author":"Jongh","year":"2002","journal-title":"Journal of the American College of Cardiology"},{"issue":"2","key":"10.1002\/14651858.CD006401.pub3-BIB41|cit41","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.atherosclerosis.2011.06.016","article-title":"Management of familial hypercholesterolemia in children and young adults: consensus paper developed by a panel of lipidologists, cardiologists, paediatricians, nutritionists, gastroenterologists, general practitioners and a patient organization","volume":"218","author":"Descamps","year":"2012","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1002\/14651858.CD006401.pub3-BIB42|cit42","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ajo.2011.08.001","article-title":"Recent statin use and cataract surgery","volume":"153","author":"Fong","year":"2012","journal-title":"American Journal of Opthalmology"},{"issue":"1","key":"10.1002\/14651858.CD006401.pub3-BIB43|cit43","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.atherosclerosis.2013.04.011","article-title":"Analysis of the frequency and spectrum on mutation recognised to cause familial hypercholesterolaemia in routine clinical practise in a UK specialist hospital clinic","volume":"229","author":"Futema","year":"2013","journal-title":"Atherosclerosis"},{"issue":"3 Suppl","key":"10.1002\/14651858.CD006401.pub3-BIB44|cit44","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jacl.2011.04.003","article-title":"Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia","volume":"5","author":"Goldberg","year":"2011","journal-title":"Journal of Clinical Lipidology"},{"issue":"12","key":"10.1002\/14651858.CD006401.pub3-BIB45|cit45","doi-asserted-by":"crossref","first-page":"5403","DOI":"10.1016\/S0021-9258(18)50610-4","article-title":"Inhibition of cholesterol synthesis with compactin renders growth of cultured cells dependent on the low density lipoprotein receptor","volume":"254","author":"Goldstein","year":"1979","journal-title":"Journal of Biological Chemistry"},{"issue":"6257","key":"10.1002\/14651858.CD006401.pub3-BIB46|cit46","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/343425a0","article-title":"Regulation of the mevalonate pathway","volume":"343","author":"Goldstein","year":"1990","journal-title":"Nature"},{"key":"10.1002\/14651858.CD006401.pub3-BIB47|cit47","first-page":"1981","article-title":"Familial hypercholesterolemia","volume-title":"The Metabolic Bases of Inherited Diseases","author":"Goldstein","year":"1995"},{"issue":"2","key":"10.1002\/14651858.CD006401.pub3-BIB48|cit48","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.atherosclerosis.2005.02.016","article-title":"Genetic screening protocol for familial hypercholesterolemia which includes splicing defects gives an improved mutation detection rate","volume":"182","author":"Graham","year":"2005","journal-title":"Atherosclerosis"},{"issue":"11","key":"10.1002\/14651858.CD006401.pub3-BIB49|cit49","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1136\/bjo.79.11.996","article-title":"Absence of effect of simvastatin on the progression of lens opacitis in a randomised placebo controlled study. Oxford Cholesterol Study Group","volume":"79","author":"Harris","year":"1995","journal-title":"Bristish Journal of Opthalmology"},{"issue":"1","key":"10.1002\/14651858.CD006401.pub3-BIB50|cit50","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0021-9150(98)00274-3","article-title":"The type of mutation in the low density lipoprotein receptor gene influences the cholesterol-lowering response of the HMG-CoA reductase inhibitor simvastatin in patients with heterozygous familial hypercholesterolemia","volume":"143","author":"Heath","year":"1999","journal-title":"Atherosclerosis"},{"issue":"7414","key":"10.1002\/14651858.CD006401.pub3-BIB51|cit51","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD006401.pub3-BIB52|cit52","unstructured":"Higgins JPT Altman DG (editors) Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011] The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD006401.pub3-BIB53|cit53","doi-asserted-by":"crossref","first-page":"c2197. doi: 10.","DOI":"10.1136\/bmj.c2197","article-title":"Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database","volume":"340","author":"Hippisley-Cox","year":"2010","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD006401.pub3-BIB54|cit54","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0002-9149(02)02393-7","article-title":"Relation of flow-mediated vasodilatation and coronary arterial calcium in young patients with heterozygous familial hypercholesterolemia","volume":"90","author":"Hoffmann","year":"2002","journal-title":"American Journal of Cardiology"},{"issue":"3","key":"10.1002\/14651858.CD006401.pub3-BIB55|cit55","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00109-005-0019-z","article-title":"Mutational analysis in UK patients with a clinical diagnosis of familial hypercholesterolemia: relationship with plasma lipid traits, heart disease risk and utility in relative tracing","volume":"84","author":"Humphries","year":"2006","journal-title":"Journal of Molecular Medicine (Berl)"},{"issue":"12","key":"10.1002\/14651858.CD006401.pub3-BIB56|cit56","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1136\/jmg.2006.038356","article-title":"Genetic causes of Familial Hypercholesterolaemia in UK patients: Relation to plasma lipid levels and coronary heart disease risk","volume":"43","author":"Humphries","year":"2006","journal-title":"Journal of Medical Genetics"},{"issue":"12","key":"10.1002\/14651858.CD006401.pub3-BIB57|cit57","doi-asserted-by":"crossref","first-page":"858","DOI":"10.7326\/0003-4819-150-12-200906160-00009","article-title":"Narrative Review: statin-related myopathy","volume":"150","author":"Joy","year":"2009","journal-title":"Annals of Internal Medicine"},{"issue":"7303","key":"10.1002\/14651858.CD006401.pub3-BIB58|cit58","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/bmj.323.7303.42","article-title":"Assessing the quality of controlled clinical trials","volume":"323","author":"J\u00fcni","year":"2001","journal-title":"BMJ"},{"issue":"7","key":"10.1002\/14651858.CD006401.pub3-BIB59|cit59","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1056\/NEJM199908123410707","article-title":"Drug treatment of lipid disorders","volume":"341","author":"Knopp","year":"1999","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD006401.pub3-BIB60|cit60","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1161\/CIRCULATIONAHA.105.565507","article-title":"Low-density lipoprotein genotype and response to pravastatin in children with familial hypercholesterolemia: substudy of an intima-media thickness trials","volume":"112","author":"Koeijvoets","year":"2005","journal-title":"Circulation"},{"issue":"10","key":"10.1002\/14651858.CD006401.pub3-BIB61|cit61","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1161\/01.ATV.13.10.1460","article-title":"Phenotypic variation among familial hypercholesterolemics heterozygous for either one of two Afrikaner founder LDL receptor mutations","volume":"13","author":"Kotze","year":"1993","journal-title":"Arteriosclerosis and Thrombosis"},{"issue":"5","key":"10.1002\/14651858.CD006401.pub3-BIB62|cit62","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1172\/JCI107670","article-title":"Familial hypercholesterolemia (one form of familial type II hyperlipoproteinemia). A study of its biochemical, genetic and clinical presentation in childhood","volume":"53","author":"Kwiterovich","year":"1974","journal-title":"Journal of Clinical Investigation"},{"issue":"8A","key":"10.1002\/14651858.CD006401.pub3-BIB63|cit63","doi-asserted-by":"crossref","first-page":"52C","DOI":"10.1016\/j.amjcard.2005.12.010","article-title":"Statin safety: A systematic review","volume":"97","author":"Law","year":"2006","journal-title":"American Journal of Cardiology"},{"issue":"11","key":"10.1002\/14651858.CD006401.pub3-BIB64|cit64","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1136\/adc.51.11.842","article-title":"Screening for familial hyper-beta-lipoproteinemia in children in hospital","volume":"51","author":"Leonard","year":"1976","journal-title":"Archives of Diseases in Children"},{"issue":"11","key":"10.1002\/14651858.CD006401.pub3-BIB65|cit65","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1001\/jamaophthalmol.2013.4575","article-title":"Association of statin use with cataracts: a propensity score-matched analysis","volume":"131","author":"Leuschen","year":"2013","journal-title":"JAMA Opthalmolology"},{"issue":"2","key":"10.1002\/14651858.CD006401.pub3-BIB66|cit66","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1161\/01.CIR.79.2.225","article-title":"Development of coronary heart disease in familial hypercholesterolemia","volume":"79","author":"Mabuchi","year":"1989","journal-title":"Circulation"},{"issue":"14","key":"10.1002\/14651858.CD006401.pub3-BIB67|cit67","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1161\/CIRCULATIONAHA.107.181946","article-title":"Drug therapy of high-risk lipid abnormalities in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, with the Council on Cardiovascular Nursing.","volume":"115","author":"McCrindle","year":"2007","journal-title":"Circulation"},{"issue":"6","key":"10.1002\/14651858.CD006401.pub3-BIB68|cit68","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/MOL.0b013e3283587522","article-title":"Familial hypercholesterolemia in children and adolescents","volume":"23","author":"McCrindle","year":"2012","journal-title":"Current Opinion in Lipidology"},{"issue":"8A","key":"10.1002\/14651858.CD006401.pub3-BIB69|cit69","doi-asserted-by":"crossref","first-page":"89C","DOI":"10.1016\/j.amjcard.2006.02.030","article-title":"Final conclusions and recommendations of the National Lipid Association Statin Safety Task Force","volume":"97","author":"McKenney","year":"2006","journal-title":"American Journal of Cardiology"},{"issue":"4","key":"10.1002\/14651858.CD006401.pub3-BIB70|cit70","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/01213011-200504000-00005","article-title":"Genetic and environmental factors affecting the response to statin therapy in patients with molecularly defined familial hypercholesterolaemia","volume":"15","author":"Miltiadous","year":"2005","journal-title":"Pharmagogenetic Genomics"},{"issue":"1-2","key":"10.1002\/14651858.CD006401.pub3-BIB71|cit71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0021-9150(93)90171-P","article-title":"Familial defective apolipoprotein B-100: A review, including some comparisons with familial hypercholesterolaemia","volume":"104","author":"Myant","year":"1993","journal-title":"Atherosclerosis"},{"key":"10.1002\/14651858.CD006401.pub3-BIB72|cit72","unstructured":"National Institute of Clinical Excellence Identification and management of familial hypercholesterolaemia - clinical guideline CG71 http:\/\/www.nice.org.uk\/nicemedia\/pdf\/CG071NICEGuideline.pdf"},{"issue":"45","key":"10.1002\/14651858.CD006401.pub3-BIB73|cit73","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1093\/eurheartj\/eht273","article-title":"Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society","volume":"34","author":"Nordestgaard","year":"2013","journal-title":"European Heart Journal"},{"issue":"6725","key":"10.1002\/14651858.CD006401.pub3-BIB74|cit74","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1136\/bmj.300.6725.667","article-title":"Lipid lowering drugs","volume":"300","author":"O'Connor","year":"1990","journal-title":"BMJ"},{"issue":"8","key":"10.1002\/14651858.CD006401.pub3-BIB75|cit75","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1161\/01.CIR.0000032466.44170.44","article-title":"ACC\/AHA\/NHLBI Clinical advisory on the use and safety of statins","volume":"106","author":"Pasternak","year":"2002","journal-title":"Circulation"},{"issue":"18","key":"10.1002\/14651858.CD006401.pub3-BIB76|cit76","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1001\/archinte.1996.00440170097011","article-title":"Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian Simvastatin Survival Study","volume":"156","author":"Pedersen","year":"1996","journal-title":"Archives of Internal Medicine"},{"issue":"2","key":"10.1002\/14651858.CD006401.pub3-BIB77|cit77","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001918","article-title":"Dietary treatment for familial hypercholesterolaemia","author":"Poustie","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD006401.pub3-BIB78|cit78","unstructured":"Scottish Intercollegiate Guidelines Network Risk estimation and the prevention of cardiovascular disease http:\/\/www.sign.ac.uk\/pdf\/sign97.pdf"},{"issue":"7","key":"10.1002\/14651858.CD006401.pub3-BIB79|cit79","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJM200202143460721","article-title":"Cerivastatin and reports of fatal rhabdomyolysis","volume":"346","author":"Staffa","year":"2002","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD006401.pub3-BIB80|cit80","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.hlc.2011.11.006","article-title":"INTERIM guidelines for the diagnosis and management of familial hypercholesterolaemia","volume":"21","author":"Sullivan","year":"2012","journal-title":"Heart Lung and Circulation"},{"issue":"1","key":"10.1002\/14651858.CD006401.pub3-BIB81|cit81","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0021-9150(97)00181-0","article-title":"Influence of genotype at the low density lipoprotein (LDL) receptor gene locus on the clinical phenotype and response to lipid-lowering drug therapy in heterozygous familial hypercholesterolemia. The Familial Hypercholesterolaemia Regression Study Group","volume":"136","author":"Sun","year":"1998","journal-title":"Atherosclerosis"},{"issue":"9874","key":"10.1002\/14651858.CD006401.pub3-BIB82|cit82","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0140-6736(12)62127-8","article-title":"Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study","volume":"381","author":"Talmud","year":"2013","journal-title":"Lancet"},{"issue":"8","key":"10.1002\/14651858.CD006401.pub3-BIB83|cit83","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1161\/01.ATV.16.8.984","article-title":"Risk factors related to carotid intima-media thickness and plaque in children with familial hypercholesterolemia and control subjects","volume":"16","author":"Tonstad","year":"1996","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"24","key":"10.1002\/14651858.CD006401.pub3-BIB84|cit84","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1161\/01.CIR.0000041253.61683.08","article-title":"Low-density lipoprotein receptor gene mutations and cardiovascular risk in a large genetic cascade screening population","volume":"106","author":"Umans-Eckenhausen","year":"2002","journal-title":"Circulation"},{"issue":"5","key":"10.1002\/14651858.CD006401.pub3-BIB85|cit85","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1469-1809.2012.00724.x","article-title":"Low-density lipoprotein receptor gene familial hypercholesterolemia variant database: update and pathological assessment","volume":"76","author":"Usifo","year":"2012","journal-title":"Annals of Human Genetics"},{"issue":"11","key":"10.1002\/14651858.CD006401.pub3-BIB86|cit86","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1161\/CIRCULATIONAHA.110.979450","article-title":"Molecular basis of autosomal dominant hypercholesterolemia","volume":"123","author":"Graaf","year":"2011","journal-title":"Circulation"},{"issue":"1","key":"10.1002\/14651858.CD006401.pub3-BIB87|cit87","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00246-013-0742-0","article-title":"Endothelial dysfunction, but not structural atherosclerosis, is evident early in children with heterozygous familial hypercholesterolemia","volume":"35","author":"Vlahos","year":"2014","journal-title":"Pediatric Cardiology"},{"issue":"2","key":"10.1002\/14651858.CD006401.pub3-BIB88|cit88","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0021-9150(01)00584-6","article-title":"Influence of LDL receptor gene mutation and apo E polymorphis on liporpotein response to simvastatin treatment among adolescents with heterozygous familial hyeprcholesterolemia","volume":"160","author":"Vohl","year":"2002","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1002\/14651858.CD006401.pub3-BIB89|cit89","doi-asserted-by":"crossref","first-page":"410","DOI":"10.3109\/07853890108995954","article-title":"Familial hypercholesterolaemia in Finland: Common, rare and mild mutations of the LDL receptor and their clinical consequences","volume":"33","author":"Vuorio","year":"2001","journal-title":"Annals of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD006401.pub3-BIB90|cit90","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.atherosclerosis.2012.10.032","article-title":"Statin treatment of children with familial hypercholesterolemia - trying to balance incomplete evidence of long-term safety and clinical accountability: Are we approaching a consensus?","volume":"226","author":"Vuorio","year":"2013","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1002\/14651858.CD006401.pub3-BIB91|cit91","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0035-8819(25)00435-0","article-title":"Screening for hyperlipidaemia in childhood. Recommendations of the British Hyperlipidaemia Association","volume":"30","author":"Wray","year":"1996","journal-title":"Journal of Royal College of Physicians London"},{"issue":"7","key":"10.1002\/14651858.CD006401.pub3-BIB92|cit92","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006401.pub2","article-title":"Statins for children with familial hypercholesterolemia","author":"Vuorio","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd006401.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,7,7]],"date-time":"2017-07-07T00:00:00Z","timestamp":1499385600000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD006401.pub3\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T22:33:30Z","timestamp":1746311610000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD006401.pub3"}},"subtitle":[],"editor":[{"given":"Alpo","family":"Vuorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,7,23]]},"references-count":92,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd006401.pub3","relation":{},"subject":[],"published":{"date-parts":[[2014,7,23]]}}}